Recombinant Human Methionyl Stem Cell Factor

Recombinant Human Methionyl Stem Cell Factor is a crucial cytokine with significant roles in hematopoiesis and various cellular processes. This engineered protein has become an invaluable tool in both research and clinical applications, particularly in areas concerning blood cell development and immune responses.

Recombinant Human Methionyl Stem Cell Factor

Key Takeaways

  • Recombinant Human Methionyl Stem Cell Factor (rhSCF) is an engineered version of naturally occurring Stem Cell Factor.
  • It is a cytokine that plays a vital role in the proliferation, differentiation, and survival of hematopoietic stem and progenitor cells.
  • Its primary function involves stimulating the development of various blood cell lineages, including mast cells and certain progenitor cells.
  • Clinical and research uses include enhancing bone marrow engraftment, supporting chemotherapy, and investigating blood disorders.
  • The “methionyl” aspect often refers to an added methionine residue, commonly used in recombinant protein production.

What is Recombinant Human Methionyl Stem Cell Factor?

Recombinant Human Methionyl Stem Cell Factor refers to a synthetically produced version of the naturally occurring human Stem Cell Factor (SCF). This protein is generated through recombinant DNA technology, meaning its genetic code is inserted into host cells (like bacteria or yeast) which then produce large quantities of the protein. The term “recombinant” highlights its engineered origin, distinguishing it from SCF isolated directly from biological tissues. The “human” designation indicates that its amino acid sequence is identical to that of the human native protein, ensuring biological compatibility and activity in human systems.

The “methionyl” component in its name often signifies the presence of an additional methionine amino acid at the N-terminus of the protein. This methionine is frequently added during the bacterial expression process to facilitate efficient protein synthesis and purification. As a cytokine, this factor, often abbreviated as rhSCF, is a signaling molecule that plays a critical role in the proliferation, differentiation, and survival of hematopoietic stem and progenitor cells. It is essential for the development of various blood cell lineages, including erythrocytes, lymphocytes, granulocytes, and notably, mast cells and melanocytes. Understanding what is recombinant stem cell factor involves recognizing its precise engineering for specific therapeutic and research applications.

Function and Uses of Recombinant Human SCF

The primary methionyl stem cell factor function is to act as a potent growth factor for hematopoietic stem cells and progenitor cells. It binds to the c-Kit receptor (CD117) on the surface of these cells, triggering intracellular signaling pathways that promote cell survival, proliferation, and differentiation. This interaction is crucial for the maintenance and expansion of the stem cell pool in the bone marrow, as well as for the development of specific cell types, most notably mast cells, which are key players in allergic reactions and immune responses. Its role extends beyond hematopoiesis, influencing germ cell development and melanogenesis.

The therapeutic and research applications of **recombinant human SCF uses** are diverse, leveraging its ability to stimulate blood cell production and support stem cell function. According to the World Health Organization (WHO), advancements in recombinant protein technology, including rhSCF, have significantly impacted the treatment of various blood disorders and cancer therapies. Some key applications include:

  • Hematopoietic Stem Cell Mobilization: Used in conjunction with other growth factors (like G-CSF) to increase the number of hematopoietic stem cells in the peripheral blood, making them easier to collect for transplantation.
  • Bone Marrow Transplantation: Administered to patients undergoing bone marrow transplantation to enhance engraftment and accelerate hematopoietic recovery after high-dose chemotherapy or radiation.
  • Treatment of Cytopenias: Investigated for its potential to treat certain types of anemia or other cytopenias (low blood cell counts) that result from bone marrow failure or chemotherapy.
  • Research into Mast Cell Disorders: Utilized in studies to understand mast cell biology, development, and their role in allergic diseases, asthma, and mastocytosis.
  • Gene Therapy and Regenerative Medicine: Explored as a component in strategies aimed at improving the efficiency of gene delivery to hematopoietic stem cells or enhancing tissue regeneration.

While rhSCF holds significant promise, its clinical use is carefully managed due to potential side effects, such as allergic reactions or exacerbation of certain conditions. Ongoing research continues to explore its full therapeutic potential and optimize its application in various medical contexts.

[EN] Cancer Types

Cancer Clinical Trial Options

Specialized matching specifically for oncology clinical trials and cancer care research.

Your Birthday


By filling out this form, you’re consenting only to release your medical records. You’re not agreeing to participate in clinical trials yet.